Inventor

SCHINDLER URSULA

DE34 patents

⚠️ This page may combine multiple inventors who share the name “SCHINDLER URSULA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHINDLER URSULA

AVENTIS PHARMA GMBH

Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same

Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceutical preparations containing same

Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators

Substituted isoindolones and their use as cyclic GMP modulators in medicaments

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

Luminescent method of detecting soluble guanylate cyclase

Method for detecting oxidized forms of soluble guanylate cyclase

Substituted 4-amino-2-aryl-tetrahydoquinazolines, their preparation, their use and pharmaceutical preparations comprising them

Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators

CASSELLA FARBWERKE MAINKUR AG

2-(N-(2-aminomethyl)amino)acetic acid derivatives to inhibit advanced glycosylation

Use of 2- (N-(2-aminoethyl)amino) acetic acid derivatives

2-(aminoalkyl)-pyrrole derivatives, to treat disorders caused by restriction in cerebral function

2-(aryl substitued)piperazinones and nootropic compositions based thereon

Pyrrolealdehydes, their preparation and their use

Pyrrole derivatives, their preparation and their use as pharmaceutical active compounds

2,5-dimethylpyrrole derivatives, their preparation and their use

Thienylpiperazinones, their preparation and their use

Substituted piperazin-1-yl-acetic acid amides

2-(aminoalkyl)pyrrolealdehydes, process for their preparation and their use

Thienylacetic acid derivatives, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof

Thienylpiperazines, the use thereof and pharmaceuticals containing these

SANOFI AVENTIS DEUTSCHLAND

Method for screening for activators of soluble guanylate cyclase having oxidized heme iron

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them

Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators

Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them

SCHINDLER URSULA

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

HOECHST AG

Multiply substituted pyridine 1-oxide compounds which are useful in treating brain disorders

LINZ WOLFGANG

Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor

LICHER THOMAS

Methods for determining sodium-proton-exchanger ligand efficiency